Janssen Pharmaceutical K.k.

This study tests whether a combination of two hormone-blocking drugs (apalutamide and a GnRH agonist) can shrink or slow the growth of advanced salivary gland cancer that has a specific protein called the androgen receptor. About 31 adults with locally advanced or spread cancer t…

This early-stage study tests a new treatment called TAR-210 in 5 Japanese patients with a type of bladder cancer that has specific genetic changes (FGFR mutations). The treatment is placed directly into the bladder to deliver the drug erdafitinib. The main goal is to see if it is…

This study tests a gene therapy for Japanese people with X-linked retinitis pigmentosa, an inherited eye disease that causes vision loss. The treatment uses a harmless virus to deliver a working gene to the retina. The main goal is to check safety, with a secondary focus on wheth…

This study tests an oral medication called JNJ-77242113 in 19 people with two rare and severe forms of psoriasis: generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP). The goal is to see if the drug can control symptoms like widespread redness, pustules, and swel…